Form 4: Intuitive Surgical SVP Sells Shares Under Pre-Arranged Trading Plan

Mark Brosius, SVP & Chief Manufacturing and Supply Chain at Intuitive Surgical Inc., reported the sale of 431 shares of common stock in early June 2025 through a pre-scheduled Rule 10b5-1 trading plan.

Summary

• Mark Brosius, Senior Vice President & Chief Manufacturing and Supply Chain at Intuitive Surgical Inc. (ISRG), filed a Form 4 reporting changes in his beneficial ownership.
• On June 5, 2025, Mr. Brosius disposed of 215 shares of common stock at a price of $560.7 per share.
• On June 6, 2025, an additional 216 shares of common stock were disposed of at a price of $563.11 per share.
• Both transactions were conducted pursuant to a Rule 10b5-1 trading plan, which is set to expire on June 13, 2025.
• Following these transactions, Mr. Brosius beneficially owns 907 shares of Intuitive Surgical common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document reports routine insider stock sales conducted under a pre-arranged 10b5-1 plan, which is a common and expected practice for executives managing their personal portfolios.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, indicating they were pre-scheduled and not based on new material non-public information, which enhances transparency and reduces concerns about opportunistic insider trading.

Negatives

• The document reports insider sales, which, while executed under a pre-arranged plan, represent a reduction in direct ownership by a key executive.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction; it solely reports insider trading activity.

Management Comments

• The transactions took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 13, 2025.

Industry Context

This Form 4 filing is a routine disclosure of insider stock transactions and does not provide information directly related to broader industry trends within the medical device or robotic surgery sectors. It reflects an individual executive's pre-planned stock sales.

Stakeholder Impact

• Shareholders: The sale of shares by a senior executive, while under a 10b5-1 plan, slightly reduces insider ownership, which could be viewed neutrally or with minor concern depending on individual investor perspective.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The Rule 10b5-1 trading plan under which these transactions occurred is set to expire on June 13, 2025.

Key Dates

Recommendation

Keywords

Intuitive Surgical, ISRG, Form 4, insider trading, stock sale, 10b5-1 plan, Mark Brosius, medical devices, robotic surgery